Dried Blood Spot Sampling for Monitoring Children With Immune-Mediated Glomerulopathies and After Kidney Transplantation.
免疫介導腎小管病及腎臟移植後兒童監測的乾血點取樣。
Kidney Int Rep 2024-11-13
SARS-CoV-2 Protein Deposition Enhances Renal Complement Activation and Aggravates Kidney Injury in Membranous Nephropathy After COVID-19.
SARS-CoV-2 蛋白沉積加強腎臟補體活化並加重 COVID-19 後膜性腎病的腎損傷。
Kidney Int Rep 2024-11-13
Randomized Trial of Patiromer on Efficacy to Reduce Episodic Hyperkalemia in Patients with ESKD Treated With Hemodialysis.
隨機試驗評估 Patiromer 在接受血液透析的末期腎病 (ESKD) 患者中減少發作性高鉀血症的療效。
Kidney Int Rep 2024-11-13
Associations of Urine Epidermal Growth Factor With Kidney and Cardiovascular Outcomes in Individuals With CKD in SPRINT.
在 SPRINT 中,尿表皮生長因子與慢性腎病患者的腎臟及心血管結果的關聯。
Kidney Int Rep 2024-11-13
Systematic Review of Individual Patient Data COVID-19 Infection and Vaccination-Associated Thrombotic Microangiopathy.
COVID-19 感染及疫苗接種相關的血栓性微血管病個案數據系統性回顧。
Kidney Int Rep 2024-11-13
Open-Label Phase 1/2 Study of Daratumumab-Based Desensitization Before Kidney Transplantation.
Daratumumab 基礎的脫敏治療在腎臟移植前的開放標籤第 1/2 階段研究。
Kidney Int Rep 2024-11-13
The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial.
使用醛固酮合成酶抑制劑 vicadrostat (BI 690517) 改善慢性腎病心腎結果的潛力:EASi-KIDNEY 試驗的理由。
Nephrol Dial Transplant 2024-11-12